Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2020 | Omics-based Platforms: Current Status and Potential Use for Cholangiocarcinoma | Chang, YC; Chen, MH; Yeh, CN; Hsiao, M | Biomolecules 10(10), 1377 | | | |
2021 | OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer | Lin, MY; Chang, YC; Wang, SY; Yang, MH; Chang, CH; Hsiao, M ; Kitsis, RN; Lee, YJ | ANTIOXIDANTS 10(11), 1808 | | | |
2019 | Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom | Yeh, CN; Chen, MH; Chang, YC; Wu, RC; Tsao, LC; Wang, SY; Cheng, CT; Chiang, KC; Chen, TW; Hsiao, M ; Weng, WH | Molecular Carcinogenesis 58(2), 270-278 | | | |
2019 | Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis | Chiou, J; Chang, YC; Jan, YH; Tsai, HF; Yang, CJ; Huang, MS; Yu, YL; Hsiao, M | Scientific Reports 9, 14624 | | | |
2020 | Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis | Chan, YC; Chang, YC; Chuang, HH; Yang, YC; Lin, YF; Huang, MS; Hsiao, M ; Yang, CJ; Hua, KT | Oncogene 39(12), 2509-2522 | | | |
2017 | Parathyroid hormone-like hormone is a poor prognosis marker of head and neck cancer and promotes cell growth via RUNX2 regulation | Chang, WM; Lin, YF; Su, CY; Peng, HY; Chang, YC; Hsiao, JR; Chen, CL; Chang, JY; Shieh, YS; Hsiao, M; Shiah, SG | Scientific Reports 7, 41131 | | | |
2015 | Platelet-like proteoliposomes enable macrophage targeting therapy | Cheng, B; Toh, E; Chen, E; Chang, YC; Chau, LY; Chen, P; Hsieh, PC | | | | |
2013 | Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: preliminary report. | Shih, SR; Chang, YC; Li, HY; Liau, JY; Lee, CY; Chen, CM; Chang, TC | Head & neck 35(1), 28-34 | | | |
2020 | PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy | Tan, KT; Yeh, CN; Chang, YC; Cheng, JH; Fang, WL; Yeh, YC; Hsu, DS; Wu, CE; Liu, CY; Chang, MS; Lu, ML; Chen, SJ; Yee, C; Hsiao, M ; Chen, MH | Journal for ImmunoTherapy of Cancer 8(1), e000485 | | | |
2014 | Promoting the selection and maintenance of fetal liver stem/ progenitor cell colonies by layer-by-layer polypeptide tethered supported lipid bilayer. | Lee, IC; Liu, YC; Tsai, HA; Shen, CN; Chang, YC | ACS applied materials & interfaces 6(23), 20654-20663 | | | |
2012 | Prostaglandin reductase 2 modulates ROS-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients. | Chang, EY; Tsai, SH; Shun, CT; Hee, SW; Chang, YC; Tsai, YC; Tsai, JS; Chen, HJ; Chou, JW; Lin, SY; Chuang, LM | The American journal of pathology 181(4), 1316-26 | | | |
2013 | Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARgamma activity. | Yu, YH; Chang, YC; Su, TH; Nong, JY; Li, CC; Chuang, LM | Journal of lipid research 54(9), 2391-9 | | | |
2022 | Rare coding variants in RCN3 are associated with blood pressure | He, KY; Kelly, TN; Wang, H; Liang, J; Zhu, L; Cade, BE; Assimes, TL; Becker, LC; Beitelshees, AL; Bielak, LF; Bress, AP; Brody, JA; Chang, YC; Chang, YC ; de Vries, PS; Duggirala, R; Fox, ER; Franceschini, N; Furniss, AL; Gao, Y; Guo, X; Haessler, J; Hung, YJ; Hwang, SJ; Irvin, MR; Kalyani, RR; Liu, CT; Liu, C; Martin, LW; Montasser, ME; Muntner, PM; Mwasongwe, S; Naseri, T; Palmas, W; Reupena, MS; Rice, KM; Sheu, WH; Shimbo, D; Smith, JA; Snively, BM; Yanek, LR; Zhao, W; Blangero, J; Boerwinkle, E; Chen, YI; Correa, A; Cupples, LA; Curran, JE; Fornage, M; He, J; Hou, L; Kaplan, RC; Kardia, SLR; Kenny, EE; Kooperberg, C; Lloyd-Jones, D; Loos, RJF; Mathias, RA; McGarvey, ST; Mitchell, BD; North, KE; Peyser, PA; Psaty, BM; Raffield, LM; Rao, DC; Redline, S; Reiner, AP; Rich, SS; Rotter, JI; Taylor, KD; Tracy, R; Vasan, RS; Morrison, AC; Levy, D; Chakravarti, A; Arnett, DK; Zhu, X | BMC genomics 23(1), 148 | | | |
2015 | Recent progress in the genetics of diabetic microvascular complications. | Chang, YC; Chang, EY; Chuang, LM | World journal of diabetes 6(5), 715-25 | | | |
2022 | Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis | Chang, YC; Li, CH; Chan, MH; Yeh, CN; Chen, MH; Hsiao, M | CELL DEATH & DISEASE 13, 391 | | | |
2016 | Regulatory circuit rewiring and functional divergence of the duplicate admp genes in dorsoventral axial patterning | Chang, YC; Pai, CY; Chen, YC; Ting, HC; Martinez, P; Telford, MJ; Yu, JK; Su, YH | DEVELOPMENTAL BIOLOGY 410(1), 108-118 | | | |
2012 | Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. | Chang, YC; Chiu, YF; Liu, PH; Shih, KC; Lin, MW; Sheu, WH; Quertermous, T; Curb, JD; Hsiung, CA; Lee, WJ; Lee, PC; Chen, YT; Chuang, LM | Clinical endocrinology 76(3), 365-72 | | | |
2016 | Reply to ‘Long-term use of acarbose and CV event: confusing finding from mega data bank’ | Chang, CH; Chang, YC; Lin, JW; Chuang, LM | Diabetic medicine : a journal of the British Diabetic Association epub | | | |
2018 | Roles of aldolase family genes in human cancers and diseases | Chang, YC; Yang, YC; Tien, CP; Yang, CJ; Hsiao, M | Trends in Endocrinology and Metabolism In Press | | | |
2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 | | | |